Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Animals were not used for multiple experiments as two of the three experiments were non-survival (due to the blood collection following DMRS and the urethane anesthesia used for fMRI) and incompatible (DMRS and PET both required labeled glucose injection, the DMRS and fMRI signals may interfere with each other, and fMRI required different anesthesia than the other two experiments)
Total Medication: 10 mg Total Liquid: 1 mL (100 units on a U-100 syringe) Concentration: 1 mg of medication for every 10 units of liquid If your prescribed dose is 2.5 mg, you would draw up 25 units
CrossRef ADAM15 promotes the progression and metastasis of hepatocellular carcinoma by activating the JNK/p38 pathway Xu Junhui, Su Mengyun Scientific Reports .2026;[Epub] CrossRef Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies Zhenxao Wang, Jun Wu, Qiao Li, Xin Wen Frontiers in Immunology .2026;[Epub] CrossRef Characterization and regulatory mechanism evaluation of C8orf33 in hepatocellular carcinoma through multiomics profiling Wei Gao, Siyi Xing, Mingjiang Liu, Xing Xie, Mei Feng, Zhipeng Quan, Housheng Wang, Zhilong He, Qianxin Hu, Huizhao Su, Shuiping Yu, Zeyuan Li Discover Oncology .2026;[Epub] CrossRef Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis Qi Zhang, Zhenwu Lei, Hezi Qing, Xingwu Xie Frontiers in Immunology .2026;[Epub] CrossRef Mechanisms and Management Strategies of Hepatocarcinogenesis Driven by Chronic Hepatitis B Comorbid with Type 2 Diabetes Qin Lou, Jiarong Cai, Jianhua Yin Microorganisms .2026
GLP-1 analog use is associated with improved disease course in inflammatory bowel disease: a report from the Epi-IIRN
